Research & Development



  上林苑的野人下山,這對大漢朝是有表率意義的,根據官府推算,全大漢足足有三成的隱匿人口都是野人,只要他們全部下山,對大漢來說意義重大。 色姐妹   “做大事才能不辜負一生所學,才能展開懷抱,青史留名。”百色综合   第三步,盡可能幫助善良的人,對這一點,雲瑯也有這深刻的認知,雖然幫助惡棍獲得的收益可能更大一些,他還是願意去幫助善良的人,畢竟,這能讓他感受到幫助人的快樂。   “雲兄,你家藏有《淮南子》也就罷了,為何你家收藏的西域地圖也跟國朝收藏的大為不同呢?你真的確定,大月氏就在蔥嶺西邊?”色尼姑AV色尼姑   “這是什麼?誰的錦書?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo